Related by context. All words. (Click for frequent words.) 80 Announce License Agreement 78 Announces FDA Clearance 77 Announce Licensing Agreement 77 Introduces Next Generation 76 FDA Clears 76 Sign Licensing Agreement 76 Awarded Patent 76 Introduces Breakthrough 75 Sign License Agreement 75 Completes Patient Enrollment 75 Announce Merger Agreement 75 Gets FDA Clearance 75 Begins Shipment 75 Receives Patent 74 Expands Portfolio 74 Receives FDA Clearance 74 Licenses Novel 74 Files IND 74 Introduces Enhanced 74 Unveils Revolutionary 74 Files Patent Application 74 Launches Next Generation 73 Commercializes 73 Announce Collaboration Agreement 73 Releases Next Generation 73 Extends Collaboration 73 Initiates Enrollment 73 Unveils Next Generation 73 Achieves Milestone 73 Initiates Clinical Trial 73 Showcases Innovative 73 Develop Innovative 73 Develop Novel 73 Unveils Breakthrough 73 Inks Licensing Deal 73 Signs License Agreement 72 Delivers Next Generation 72 Develop Next Generation 72 Awarded Patents 72 Settles Patent Dispute 72 Introduces Revolutionary 72 Restructures Operations 72 Ships #th 72 Completes Merger With 72 Initiates Clinical 72 Introduces Innovative 72 Announces Licensing Agreement 72 Strengthens Position 72 Submits NDA 72 Settle Patent Dispute 72 Announces Discontinuation 72 Introduces Unique 72 Debuts Next Generation 72 Unveils Latest 72 Receives Milestone Payment 71 Announces Initiation 71 Expand Collaboration 71 Unveils Innovative 71 Completes Enrollment 71 Introduces Expanded 71 Signs Merger Agreement 71 Develops Novel 71 Receives Orphan Drug Designation 71 Broadens Its 71 Jumps Higher 71 Signs Licensing Agreement 71 platform HDL Mimetic 71 Streamlines Operations 71 Introduces Affordable 71 Initiates Phase II 71 Receives CE Marking 71 Amend Merger Agreement 71 Initiates Dosing 71 Sinks Lower 71 Announce Collaboration 71 Q2 Loss Narrows 71 Receives Orphan Drug 71 Taglich Brothers Initiates Coverage 71 Successfully Completes Acquisition 71 Announces License Agreement 71 Issued Patent 71 Announces Immediate Availability 70 Licenses Patents 70 Enters Into Exclusive 70 Announce Availability 70 Successfully Concludes 70 Restructures Debt 70 Accelerate Commercialization 70 Settles Patent Litigation 70 Announces Divestiture 70 Extend Collaboration 70 Q3 Loss Narrows 70 Develops Breakthrough 70 Files Shelf Registration Statement 70 Launches Unique 70 Enrolls First 70 Presents Positive 70 Successfully Completes Tender Offer 70 Therapeutic Competitors Companies 70 Receives Approvable Letter 70 Unveils Expanded 70 Settle Patent Litigation 70 Q3 Loss Widens 70 FDA Okays 70 Successfully Completes Phase 70 Q2 Adj 70 Achieves ISO #:# Certification [002] 70 AUDIO PROVIDED BY 70 Delivers Breakthrough 70 Enters Into Licensing Agreement 70 Welcomes Analyst Initiation 70 Files Patent 70 Begins Shipping 70 Announce Expanded 70 Unveils Groundbreaking 70 Achieves ISO # 70 Provides Shareholder 69 Reduces Risk 69 Submits Biologics License Application 69 Strengthens Leadership 69 Earnings Postmortem 69 Guides Inline 69 Therapeutic Competitors Report 69 Receives Favorable 69 Collaborators Present 69 Unveils Upgraded 69 Q1 Loss Narrows 69 Extend Partnership 69 Announces Rebranding 69 Completes Recapitalization 69 Receives Clearance 69 Submits Application 69 Patent Issued 69 Finalizes Purchase 69 Introduces Newest 69 Secures Patent 69 Obtains Exclusive License 69 Obtains Patent 69 Introduces Groundbreaking 69 Submits IND 69 Collaborates With 69 Buys Majority Stake 69 Develops Innovative 69 Introduces Powerful 69 Named Exclusive Distributor 69 Launches Expanded 69 Showcases Latest 69 Thewallstreetleader.com Profiles 69 Shareholders Approve Acquisition 69 Amends Agreement 69 Could Revolutionize 69 Expands Capabilities 69 Develops Next Generation 69 Receives SFDA Approval 69 Announces Organizational Changes 69 Receives NASDAQ 69 Showcases Next Generation 69 Confirms Commitment 69 Completes Divestiture 69 Provides Update Regarding 69 Board Authorizes 69 Presents Preclinical Data 69 Completes Tender Offer 69 Webcast Presentations 69 Inc. LATEST NEWS 69 Settle Litigation 69 Q4 Loss Narrows 69 Announces Favorable 69 Releases Enhanced 69 Q2 Loss Widens 69 Q1 Profit Surges 68 Commences Phase 68 Announces Enhancements 68 Finalizes Acquisition 68 Expand Relationship 68 Announce Definitive Agreement 68 Wins Patent Infringement 68 Strengthens Its 68 Announce Initiation 68 Exploring Strategic Alternatives 68 Demonstrates Next Generation 68 Inks Distribution 68 Present Preclinical Data 68 Q1 Adj 68 Appoints Experienced 68 Achieves Significant 68 FDA Approvals 68 Launches Innovative 68 Reveals Positive 68 Launches Groundbreaking 68 Unveils Powerful 68 Further Strengthens 68 AnaSpec Introduces 68 Provides Comprehensive 68 Demonstrates Potential 68 Enters Oversold Territory 68 Unveils Enhanced 68 Retains CCG Investor Relations 68 Begins Dosing 68 Announces Effective Date 68 Attracting Bullish Investors 68 Announces Additions 68 Boosts Productivity 68 BioSante Pharmaceuticals Announces 68 Narrows Guidance 68 Receives Certification 68 Stockholders Approve Acquisition 68 Enhances User Experience 68 Completes Purchase Of 68 siRNA Delivery 68 Unsolicited Proposal From 68 Demonstrates Innovative 68 Outlines Strategy 68 Releases Latest Version 68 Announce Completion 68 Veeco Introduces 68 Achieves Breakthrough 68 Finalizes Sale 68 Q1 Loss Widens 68 Jointly Launch 68 Patent Lawsuit Against 68 Announces Tentative Approval 68 COO Exercises Options 67 visit www.genenews.com 67 Concludes Acquisition 67 Enters Into Collaboration 67 SIX RO ROG 67 Bullish Average Crossover 67 FY# Loss Widens 67 Completes Buyout 67 Q4 Loss Widens 67 Unveil Next Generation 67 Secures Financing 67 Submits Response 67 Expands Relationship With 67 Successfully Tested 67 Q3 Profit Decreases 67 Receive Milestone Payment 67 Significantly Improves 67 Achieves Positive 67 VP Exercises Options 67 Announces Stock Buyback 67 Demonstrates Significant 67 Receives Favorable Ruling 67 Demonstrate Innovative 67 Secures Funding 67 Q4 Profit Plunges 67 Reports Preclinical Data 67 Inc Therapeutic Competitors 67 NanoInk logo 67 Toshiba Develops 67 CEO Exercises Options 67 Expands Availability 67 Launches Enhanced 67 Fortifies 67 Collaborators Publish 67 Subsidiary Enters 67 Announce Breakthrough 67 DayTradersDigest.com Profiles 67 Director Exercises Options 67 Test Detects 67 Q3 Adj 67 Demonstrates Interoperability 67 Announces Publication 67 NewsBite Downgrade Puts Pressure 67 Continues Aggressive 67 Completes Installation 67 Enters Into License Agreement 67 Awarded Qualifying Therapeutic 67 Announces Stockholder Approval 67 Expands Commitment 67 Delivers Comprehensive 67 Helps Identify 67 JAK2 Inhibitor 67 Jointly Offer 67 Delivers Unparalleled 67 Jointly Develop 67 Launches Redesigned Website 67 Settles Litigation 67 Announce Exclusive 67 Markettelegraph.com 67 Spins Off 67 Q1 Profit Decreases 67 Extends Capabilities 67 Successfully Tests 67 Presents Preclinical 67 Receives Subpoena 67 CysDisplay R 67 Significantly Increases 67 Spins Out 67 Voluntarily Withdraw 67 Releases Upgraded 67 SVP Exercises Options 67 Receives Approvals 67 PRN FDA Approves 67 Shows Promise Against 67 R MSCRAMM 67 Completes Acquisitions 67 Motorola Invests 67 Files Patents 67 Completes Reorganization 67 Tessera Licenses 67 Earns Certification 67 Syneron logo 67 Prolongs Survival 67 Offers Enhanced 67 Announces Recapitalization 67 Q4 Profit Surges 67 Explore Strategic Alternatives 67 Broadens Scope 67 Demonstrates Latest 67 Stockholders Approve Merger 67 Shows Promising 67 Enters Strategic 67 Enables Easy 67 Delivers Enhanced 67 Q2 Profit Surges 67 Earns Milestone Payment 67 Crofelemer budesonide foam 67 Board Unanimously Rejects 67 Prove Effective 67 Successfully Launches 67 RNA Amplification 67 Provides Guidance 67 Acquires Controlling Interest 67 Successfully Closes 67 Q4 Profit Soars 66 Expands Scientific Advisory 66 Deliver Presentation 66 Bearish MACD 66 Celebrates Decade 66 Unveils Newest 66 Launches Breakthrough 66 Terminate Merger Agreement 66 Appoints Seasoned 66 Other OTC MNDP 66 Announces Successful Completion 66 Files Annual Report 66 Changes Ticker Symbol 66 Ventures Invests 66 Boosts Buyback 66 Regains NASDAQ 66 Completes Restructuring 66 MONSTERSTOX.COM Monsterstox.com 66 Expands Globally 66 Accelerates Expansion 66 Beats Raises Guidance 66 Expands Capacity 66 Initiates Clinical Trials 66 Files Investigational 66 Obtains License 66 Engages CHF Investor Relations 66 Expands Scope 66 Novel Antibody 66 Inks License 66 Movers Roundup 66 Secures Additional 66 Achieves Primary Endpoint 66 Receives Funding 66 Daytradersdigest.com 66 Announce Launch 66 Daytradersdigest.com Profiles 66 Becomes Wholly Owned Subsidiary 66 Demonstrate Latest 66 IG HCR ;) CO 66 Achieves Certification 66 Introduce Next Generation 66 Further Validates 66 HuCAL PLATINUM R 66 Q4 Profit Decreases 66 Genentech sanofi aventis 66 Deliver Powerful 66 NEC Develops 66 Terminates Merger Agreement 66 Clinical Study Shows 66 TM Aganocide 66 Post Earnings Checkup 66 Extends Relationship With 66 Forges Strategic 66 Extends Relationship 66 Announces Early Termination 66 CFO Exercises Options 66 Achieves Milestones 66 Presents Positive Preclinical 66 Therapeutic Antibody 66 Declares Regular Cash Dividend 66 Announces Reseller Agreement 66 EVP Exercises Options 66 Identifies Potential 66 Non Invasive Treatment 66 COMUNICADO DE 66 Provides Preliminary 66 Dry Powder Inhalers 66 includes Dideco CarboMedics 66 Proven Effective 66 Announce Reseller Agreement 66 Revitalizes 66 Inc. Nasdaq OXGN 66 Obtains Approval 66 Acquires Assets 66 Improves Efficiency 66 Closes Acquisition Of 66 Sets Second Quarter 66 Immunomedics Announces 66 Acquire Majority Stake 66 Files Voluntary 66 Provides Updated 66 Shareholders Approve Sale 66 3M Completes Acquisition 66 Expands Internationally 66 Obtains Exclusive Rights 66 TRADESHOW SOURCE 66 Bearish Speculation 66 Buy Privately Held 66 Enters Exclusive 66 Balloon Catheters 66 Platform Enables 66 Acquires Exclusive 66 Ups Guidance 66 Finalizes Purchase Of 66 Delivers Strong 66 Unveils Enhancements 66 Deloitte commends 66 Completes Expansion 66 Announces Poster Presentations 66 Sign Reseller Agreement 66 Retains Leading 66 Mutually Agree 66 Achieves Profitability 66 Achieves ISO #:# Certification [001] 66 Novartis Novo Nordisk 66 Receives Positive 66 Forges Partnership 66 Consummates 66 Lowers Guidance 65 Photovoltaic Module 65 Terminates Agreement 65 TheWallStreetLeader.com Profiles 65 Announces Adjournment 65 Deliver Comprehensive 65 Strengthens Balance Sheet 65 Wins Prestigious Award 65 Q2 Profit Soars 65 SWOT Analysis Aarkstore Enterprise 65 Delivers Powerful 65 Completes Financing 65 Q3 Profit Soars 65 Canaccord Genuity Maintains Hold 65 Reinforces Leadership 65 Authorizes Additional 65 Announce Early Termination 65 Offers Customized 65 Demonstrates Statistically Significant 65 CRWESelect CRWESelect.com Highlights 65 Updates Guidance 65 Broadens Product 65 Takes Majority Stake 65 Sign Definitive Merger 65 Significantly Enhances 65 Submits Supplemental 65 Completes Refinancing 65 Launches Generic Version 65 Restate Financials 65 Updates Fourth Quarter 65 candidates Azedra TM 65 Dramatically Expands 65 Announces Stock Repurchase 65 Adopts Stockholder Rights 65 Inc.today announced 65 Improves Outcomes 65 Announce Commencement 65 Boosts Guidance 65 FY# Loss Narrows 65 CybeRelease Decliners 65 Reaffirms Fourth Quarter 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 COMPLETES ACQUISITION OF 65 PerkinElmer Acquires 65 Retains Investor Relations 65 Extends Leadership 65 Completes Reverse Merger 65 Beats Estimates Analyst Blog 65 Traders Hedging Bets 65 BIOTECHNOLOGY SOURCE 65 Purchases Moore Microprocessor 65 Proves Successful 65 lead molecular radiotherapeutic 65 Reports Positive 65 Terminates Contract 65 Reports Significantly Improved 65 Verisyse TM intraocular lenses 65 Settle Patent 65 Regains Nasdaq 65 Sign Definitive Agreement 65 Demonstrates Sustained 65 Achieves Record Sales 65 Bullish Technical Alert 65 Granted Orphan Drug 65 Assets Acquirer Company 65 Signs Distribution 65 Adsorbent 65 Confirms Significant 65 Shown Effective 65 IND Application 65 Wins Summary Judgment 65 Declares Quarterly Dividends 65 Veronate R 65 Deliver Integrated 65 Files Provisional 65 Commercialize 65 Announces Dismissal 65 Evaluate Strategic Alternatives 65 Extends Reach 65 Receives ISO #:# [001] 65 Reaffirms Outlook 65 Reduces Workforce 65 contain Totally Degradable 65 Jointly Promote 65 Unwraps 65 Receives ISO #:# [002] 65 Backs FY# Outlook 65 Endures Analyst Downgrade 65 Sets Record Date 65 Continues Momentum 65 Flagship Product 65 Shareholders Approve Merger 65 Enables Faster 65 Moving Average Crossover Alert 65 Earnings Scorecard 65 Announces Definitive Agreement 65 Sharpens Focus 65 Provides Clarification 65 Supercharges 65 Establishes Joint Venture 65 candidates Azedra 65 Raser Technologies Announces 65 Tumor Targeting 65 R Digirad Imaging 65 Extends Commitment 65 Reconfirms 65 Demonstrates Positive 65 Q1 Profit Soars 65 Complete Merger 65 Deliver Enhanced 65 Announces Signing 65 Plans Buyback 65 Initiates Voluntary Recall 65 Exec Exercises Options 65 Acquisition Strengthens 65 AGREEMENTS SOURCE 65 Report companiesandmarkets.com adds 65 Expands Functionality 65 Host Teleconference 65 Inks Licensing Agreement 65 Announces Latest Version 64 Establishes Strategic 64 Q2 Profit Decreases 64 Study Demonstrates 64 Aquires 64 Stockwire.com OTC 64 Guides Below 64 Initiates Phase 64 Schedules Webcast 64 Reveals Receipt 64 Acquire Assets 64 Increases Share Repurchase 64 Inks Deals 64 Completes Debt Refinancing 64 Announce Successful Completion 64 Q3 Profit Surges 64 Rated Speculative Buy 64 Bearish Pressure Building 64 Reduces Pain 64 Demonstrates Commitment 64 Lung Cancer Drug 64 Deliver Turnkey 64 Sanofi Aventis Schering Plough 64 Reaffirms FY# Outlook 64 Sirna Therapeutics StrataCom 64 Contrast Enhanced 64 Obtains Exclusive 64 Associatesfortune.com 64 Concludes Successful 64 Completes Merger 64 var arrMeta = 64 Closes Acquisition 64 CRWEWallstreet.com Stock Report 64 Successfully Deploys 64 Effectively Treats 64 Plans Job Cuts 64 Trims Loss 64 Microwave Ablation System 64 Q4 Profit Climbs 64 http:/www.appliedbiosystems.com/ 64 Lowers Q4 64 Confirms Filing 64 Q2 Profit Plunges 64 Commercialize Novel 64 Introduces Rugged 64 Naglazyme R 64 Announces Spin Off 64 First Patient Treated 64 PPD Declares 64 Helps Prevent 64 * vwd PRN 64 Upside Looming 64 Inc. OTCBB ECTE 64 Novel Therapeutic 64 Drug Fails 64 Inc. OTCBB MNDP 64 Enters Into Definitive 64 Awarded GSA Schedule 64 Namenda Memantine HCl 64 Enters Into Strategic 64 Releases Latest 64 Nanophase Announces 64 Technol 64 Receives Tentative Approval 64 Lupus Drug 64 Canaccord Genuity Reiterates Buy 64 Reports Profitable 64 Single Dose 64 Drug Eluting Coronary Stent 64 Reiterates Fiscal 64 Trims Outlook 64 Settles Patent Suit 64 #.#.# Meldung [001] 64 MARKETING AGREEMENTS SOURCE 64 Sets Quarterly Dividend 64 www.biosite.com 64 Receives Commitment 64 Enters Into Joint Venture 64 Attains Gold Certified Partner 64 Doubles Capacity 64 Shareholders Approve Merger Agreement 64 Posts Wider 64 Micro electromechanical 64 PAUL Minn.MN 64 Calls Purchased 64 Electrically Conductive 64 INDICATED LOWER 64 Joins OTCQX 64 Provide Comprehensive 64 CEO Discusses F#Q# [001] 64 For Undisclosed Terms 64 Announces Presentation 64 Acquires Remaining Interest 64 Acquirer Company 64 Net Loss Widens 64 Finalize Agreement 64 Explores Strategic Alternatives 64 Increases Commitment 64 Announces Share Repurchase 64 CFO Resigns 64 Retains OTC 64 Posts 2Q 64 Puts Purchased 64 Files Definitive Proxy 64 researches develops licenses 64 Licensing Pact 64 Ink Pact 64 4Q Profit Jumps 64 Revises FY# Outlook 64 Achieves Record Revenue 64 Achieves Prestigious 64 Updates Outlooks 64 Uracyst R Test 64 Stays Neutral 64 Inks Pact 64 Unveils Latest Version 64 Announces Issuance 64 1Q Profit Triples 64 Provides Complete 64 Beats Analyst 64 MarketsandMarkets Global 64 MARKETING AGREEMENTS PRODUCT SOURCE 64 PRODUCT SOURCE 64 Review Strategic Alternatives 64 CONFERENCE CALLS SOURCE 64 TSMC Collaborate 64 Delivers Improved 64 Celebrates Tenth Anniversary 64 molecular imaging radiopharmaceutical 64 RealPennies.com RealPennies.com 64 Directors Elects 64 Q2 Profit Declines 64 4Q Profit Surges 64 Amends Credit 64 Proposed Buyout 64 Patent Infringement Suit Against 64 Establish Joint Venture 64 Expects 1Q 64 Regains Compliance With 64 Closes Previously Announced 64 Delivers Exceptional 64 Announces Revised 64 Continues Commitment 64 Announce Formation 64 Q2 Profit Slips 64 Q4 Profit Jumps 64 Record Third Quarter 64 Winning Streak Continues 64 Completes Asset 64 Completes Initial 64 var arrUrl = 64 Creates Innovative 64 Makes Unsolicited Bid 64 Attains 64 Receives Recognition 64 Genentech Wyeth Pharmaceuticals 64 var arrContent = 64 Inc. Attracting Bullish 64 MarrowXpress 64 Awarded GSA 64 Posts 4Q 64 Media NewsEdge STOCK MARKETING 64 Underscores Commitment 64 Q3 Profit Jumps 64 :/ finance.yahoo.com q 64 Shows Statistically Significant 64 Enters Into Long Term 64 Commence Phase 63 Inc. www.micromet inc.com 63 Gets Bearish Confirmation 63 Approaching Resistance 63 Teva Provides Update 63 Begins Tender Offer 63 visit http:/www.neogenomics.org 63 Helps Predict 63 Furthers Commitment 63 Bearish Average Crossover 63 Successfully Treats 63 Inc. Rated Speculative 63 Announces Postponement 63 Successfully Passes 63 Improves Accuracy 63 Files Shelf Registration 63 BayStreet.ca Research Alert 63 com BlackSingles.com R 63 Strengthens Commitment 63 Tyrosine Kinase Inhibitor 63 Announces Sponsorship 63 Q3 Profit Drops 63 Protein Synthesis 63 Named CES Innovations 63 Manufacturer Selects 63 Schedules Fiscal 63 Unveil Latest 63 Provides Updates 63 Drug Candidate 63 Acquire Controlling Interest 63 Posts Narrower Loss 63 Completes Successful 63 Formalizes 63 Initiate Clinical Trial 63 Delivers Innovative 63 AVI BioPharma Announces 63 CEO Discusses Q1 63 Provides Unprecedented 63 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 63 Helps Manage 63 Announce Strategic 63 Awarded Prestigious 63 Study Shows Benefits 63 Signs Definitive Merger Agreement 63 Accelerates Growth 63 Finalize Joint Venture 63 Adopts Shareholder Rights 63 Announce Interoperability 63 Contrast Agents 63 Announce Agreement 63 High Growth Forecasted 63 Puts Sold 63 Receives CE 63 StockPreacher.com Issues Trading 63 SPL# Gel vaginal microbicide 63 liners promos voicetracking 63 Equipment Deals 63 Immunoassay Systems 63 Renewably Sourced 63 Bullish Speculation 63 Reports Inducement Grants 63 Launches Redesigned 63 Settles Dispute 63 Financial Officer# 63 Declares Qtr 63 ADDING MULTIMEDIA 63 PRN4 63 Genotyping Test 63 Identifies Key 63 ORLive Presents 63 Being Studied 63 Bullish Engulfing Formed 63 Devices PTCs 63 Announces Departure 63 Completes Redemption 63 Retains CCG Elite 63 ANADIGICS Announces 63 Patient Enrollment 63 Achieves ISO 63 Reports Double Digit 63 Revises Fiscal 63 Subsidiary Acquires 63 markets COLAZAL 63 Expands Distribution 63 Bullish Engulfing Pattern 63 Monetizes 63 Directors Authorizes 63 Q2 Profit Rises 63 Voluntarily Withdraws 63 Provide Enhanced 63 Posts Wider Loss 63 Announces Cancellation 63 Circulating Tumor Cells 63 Extends Tender Offer 63 website www.celsion.com 63 Ramps Up Production 63 Closes Buyout 63 Announces Repurchase 63 Lifts FY# Outlook 63 STERIS Corporation Announces 63 Settles Patent Lawsuit 63 Announces Availability 63 RNAi Therapeutic 63 PROFILE CO 63 Empowers Consumers 63 Color Kinetics logo 63 Launches Pioneering 63 Q1 Profit Slips 63 Authorizes Stock Repurchase 63 Successfully Completed 63 Announces Reverse Split 63 Guides Above 63 News Unternehmensnachrichten DGAP Adhoc 63 Announces Expanded 63 Announces Profitable 63 Extends Expiration Date 63 Boosts Quarterly Dividend 63 INDICATED HIGHER 63 Announcement acc 63 Ion Trap 63 -Pahuta 63 Psoriasis Drug 63 Reschedules Fourth Quarter 63 Freeze Drying 63 PATHFINDER ® TRACER 63 TSX Delisting Review 63 Named Fastest Growing 63 Sells Shares 63 visit www.virtualscopics.com 63 Protein Biomarker 63 products visit www.#M.com/touch# 63 Guidelines Issued 63 Registration Statement Declared Effective 63 Q1 Profit Plunges 63 Announce Expiration 63 Affirms Guidance 63 dedicated CHAT ROOM 63 include FIS NYCE 63 Molecular Diagnostic 63 Joins Hands 63 Stock Downgraded 63 Regenerative Cell 63 Guides FY# Quick Facts 63 Files Registration Statement 63 Kyocera Lenovo palmOne 63 Small Molecule 63 Ondansetron Orally Disintegrating Tablets 63 Essence Ultra LifePak 63 Revises Q4 63 PRN8 63 Masimo SET Signal Extraction 63 ExxonMobil Fluor 63 Improves Quality 63 Cerebral Somatic Oximeter 63 Announces Job Cuts 63 Refocuses 63 Reduces Cost 63 Magazine Recognizes 63 Approves Share Repurchase 63 Announces Formation 63 Demystifies 63 robust MALDI Biotyper 63 Immunotherapeutic 63 Launches Latest Version 63 Reversal Soon 63 Generic Versions 63 Affirms Commitment 63 Completes Transaction 63 Q1 Profit Declines 63 Launches Redesigned Web 63 Becomes Authorized 63 Flamel Technologies Announces 63 Vascular Grafts 63 Signs Agreements 63 Slashes Guidance 63 CEPHEID 63 Dual Wavelength 63 Narrows 4Q Loss 63 Announces Dosing 63 NASDAQ. 63 Withdraws Proposal 63 Signs Reseller Agreement 63 Enlarges 63 Selects Camstar 63 Regains Compliance 63 Q4 Profit Declines 63 Reportlinker Adds Global 63 Puts Itself 63 Enter Into 63 By Phillip Ramati 63 Above Estimates 63 Help Detect 63 Posts 4Q Profit 63 Engages Investor Relations 63 Complies With 63 Awarded Contract Extension 62 REMINDER ORLive Presents 62 Intuit Juniper Networks 62 Diagnostic Tests 62 Technicals Showing Bullish 62 Put Volume Surges 62 Releases Second Quarter 62 Reacquires 62 Sells Remaining 62 INDUSTRY ASSESSMENTS 62 Corporation NasdaqGS 62 AP Photo NAI# 62 Novel Inhibitor 62 Shares Plunged What 62 Scientists Develop 62 Posts Wider 4Q Loss 62 Q1 Profit Rises 62 1Q Profit Declines 62 Neurosurg 62 Novel Oral 62 www.qiagen.com 62 Raytheon Rockwell Collins 62 Boosts Qtr 62 Selects BoardVantage 62 Increases Productivity 62 Pathogen Detection 62 OKs Buyback 62 Sees 2Q 62 OTCStockExchange.com Stock Alert 62 Enhances Functionality 62 Accelerate Adoption 62 Signs Definitive 62 Enters Joint Venture 62 By PHILLIP RAMATI 62 Other OTC USOG 62 HuCAL GOLD R 62 Signs Framework Agreement 62 Updates Shareholders 62 Achieves Oracle Validated 62 International www.iscointl.com 62 Generx ® 62 Backs FY# EPS 62 ASML Novellus Systems 62 Directors Declares Dividend 62 BioElectronics Corporation Announces 62 Vishay Measurements Group 62 Wins Coveted 62 otcstockexchange.com 62 Enable Next Generation 62 Solvent Based 62 Announces Concurrent Offerings 62 Significantly Expand 62 Releases Third Quarter 62 Increases Capacity 62 Commences Phase III 62 Corp. LATEST NEWS 62 Publishes Updated 62 Shows Efficacy 62 Reaffirms FY# EPS 62 markets Ioteq iodine 62 Blood Clotting 62 widens Quick Facts 62 Stock Upgraded 62 Receives Prestigious Award 62 NDA Submission 62 Deliver Next Generation 62 Prostate Cancer Vaccine 62 Inc GPRO 62 Bioresorbable 62 Recent Trades 62 Cephalon GlaxoSmithKline 62 Curon Control 62 Revolutionizes 62 Launches Revamped 62 Trend Continues Down 62 Recommends Approval 62 Could Detect 62 Maintains Strong 62 Acquires Majority 62 BioPharmaceutical 62 Inks Agreement 62 ALTROPANE R 62 Subsidiary Completes Acquisition